Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

Healthcare Cannabis
FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.


CSE:HUGE - Post by User

FSD Pharma Inc
Bullboard Posts
User Avatar Image
(48)
•••
Comment by ChiefBroncoon Jul 26, 2019 1:31pm
98 Views
Post# 29964761

RE:RE:RE:RE:RE:RE:RE:RE:RE:arcview and institutional funds

RE:RE:RE:RE:RE:RE:RE:RE:RE:arcview and institutional funds
ChiefBronco wrote:
TANT3HILD3 wrote:
ChiefBronco wrote: I contacted them in the beginning of the week and they confirmed they had product ready to go so I guess your wrong again. They will be open to medical users very very soon thats what the gentleman told me, and no its not fake news its very honest truth so if you dont believe me go ahead and call them for yourself....


So you're saying they have violated their quiet period they say they are in? I'm sure the regulators would like to hear more about it. Please go on. Either that or quiet period is just horse sheet, but no surprise there either.






Quiet period only apply to executive from the company not share holders and employees. I called as a client to buy product and the employee told me that they had product in the vault and they would be ready very very soon.


what tante are you to stupid to pick up the phone and call them.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities